Nplate 125 mcg Injection
RxNorm 2201540
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2201540 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Nplate 125 mcg Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Nplate 0.125 mg Injection
(Atom ID: 11451047)
PSNPrescribable
Prescribable Name (PSN):
Nplate 125 mcg Injection
(Atom ID: 11451057)
SYPrescribable
Synonym (SY):
Nplate 125 mcg Injection
(Atom ID: 11451058)
SBDPrescribable
Semantic Branded Drug (SBD):
Romiplostim 0.125 mg Injection [Nplate]
(Atom ID: 11451046)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
RomiPLOStim 0.125 mg Injection [Nplate]
(Atom ID: 11454120)
Patient Education
Romiplostim Injection
Romiplostim injection is used to increase the number of platelets (cells that help the blood to clot) in order to decrease the risk of bleeding in adults who have immune thrombocytopenia (ITP; idiopathic thrombocytopenic purpura; an ongoing condition that may cause easy bruising or bleeding due to an abnormally low number of platelets in the blood). Romiplostim injection is also used to increase the number of platelets in order to decrease the risk of bleeding in children at least 1 year of age who have had ITP for at least 6 months. Romiplostim injection should only be used in adults and children 1 year of age or older who cannot be treated or have not been helped by other treatments, including other medications or surgery to remove the spleen. Romiplostim injection should not be used to treat people who have low platelet levels caused by myelodysplastic syndrome (a group of conditions in which the bone marrow produces blood cells that are misshapen and does not produce enough healthy blood cells) or any other conditions that cause low platelet levels other than ITP. Romiplostim injection is used to increase the number of platelets enough to lower the risk of bleeding, but it is not used to increase the number of platelets to a normal level. Romiplostim is in a class of medications called thrombopoietin receptor agonists. It works by causing the cells in the bone marrow to produce more platelets.
[Learn More]
* Please review the disclaimer below.